Duality Advisers’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,396
Closed -$756K 575
2023
Q2
$756K Buy
+1,396
New +$763K 0.1% 331
2022
Q2
Sell
-1,606
Closed -$814K 629
2022
Q1
$814K Buy
+1,606
New +$770K 0.09% 377
2021
Q2
Sell
-4,710
Closed -$2.17M 554
2021
Q1
$2.17M Buy
4,710
+2,446
+108% +$1.2M 0.19% 194
2020
Q4
$1.21M Sell
2,264
-2,446
-52% -$1.2M 0.09% 308
2020
Q3
$2.26M Buy
4,710
+1,373
+41% +$673K 0.14% 199
2020
Q2
$1.5M Buy
+3,337
New +$1.49M 0.14% 203

Other funds holding CHE

Duality Advisers's CHE Position: Q3 2023 in Review

Duality Advisers sold out of Chemed (CHE) in Q3 2023, closing a stake of 1,396 shares — an estimated $756K sold.

Duality Advisers first reported a position in CHE in Q2 2020 and held it in 6 quarters. The position peaked at $2.26M in Q3 2020. 457 funds tracked by Wall St. Rank hold CHE as of Q3 2023.

  • Duality Advisers reported no remaining Chemed position as of Q3 2023 after selling out during the quarter.
  • Duality Advisers sold 1,396 Chemed shares in Q3 2023, an estimated $756K.
  • Duality Advisers first reported a position in Chemed in Q2 2020 and held it in 6 quarters.
  • Duality Advisers's Chemed position peaked at $2.26M in Q3 2020.
  • 457 funds tracked by Wall St. Rank held Chemed as of Q3 2023.

Based on Duality Advisers's 13F filing for Q3 2023, filed 2 Nov 2023.